<DOC>
	<DOCNO>NCT02820051</DOCNO>
	<brief_summary>Flexible bronchoscopy ( FB ) fundamental procedure diagnosis treatment respiratory disease . Although midazolam recommend sedative agent guideline , propofol gain popularity due short recovery time , however , evidence propofol use sedation FB scarce . There little evidence transcutaneous CO2 pressure ( PtcCO2 ) behavior among patient sedate propofol administer non-anesthesiologist combination intravenous opioids analgesia cough inhibition . The investigator perform randomize control trial determine whether non-anesthesiology-administered balanced-sedation propofol relate high value value PtcCO2 compare guideline-based sedation ( midazolam opioid ) . The investigator include data outpatient 18 year old indication FB university hospital northern Mexico . Secondary outcomes recuperation time , patient satisfaction adverse effect .</brief_summary>
	<brief_title>Non-anesthesiologist-administered Propofol During Flexible Bronchoscopy</brief_title>
	<detailed_description>The investigator prospectively include ambulatory patient age &gt; 18 year indication flexible bronchoscopy . Bronchoscopic procedure perform resident Respiratory Critical Care Medicine subspecialty supervision attendant professor university-tertiary-referral center northern Mexico . Patients tracheostomy , know allergy drug use procedural sedation , inability answer satisfaction questionnaire , psychiatric illness , pregnancy , ASA class IV V , exclude . Patients randomly assign receive sedation midazolam propofol . In group midazolam initial dose 0.05 mg/kg propofol group , start dose 0.1 mg /kg . Additional dos correspond drug ( 2 mg midazolam 10 mg propofol ) allow reach score level 3 4 ObserverÂ´s assessment alertness/ sedation scale . All patient receive nalbuphine start dose 2 mg additional dos 1 mg necessary . Prior insertion bronchoscope , lidocaine spray apply nasal mucosa pharynx bronchoscope nasal insertion , pharynx bronchoscope oral insertion . Topical lidocaine apply use spray-as-you-go technique , maximum dose 7 mg/kg . In group , transcutaneous CO2 measurement carry system SenTec digital monitoring ( Artemis Medical , Kent , London ) apply Stow-Severinghaus ( V-Sign sensor ) type sensor ear lobe . All patient receive supplementary oxygen monitor intermittent non-invasive blood pressure measurement every 3 min continuous EKG SO2 surveillance . The assessment state residual sedation perform Aldrete scale five , 10 15 minute complete FB . At time discharge bronchoscopy suite , satisfaction questionnaire apply patient . Sedation analgesia prescribe resident responsible conduct FB without support specialist anesthesiology . One collaborator blind study group patient belong record data derive procedure . The Bronchoscopist blind PtcCO2 value .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>Ambulatory patient age &gt; 18 year indication flexible bronchoscopy . tracheostomy know allergy drug use procedural sedation inability answer satisfaction questionnaire psychiatric illness , pregnancy ASA class IV V</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>bronchoscopy</keyword>
	<keyword>conscious sedation</keyword>
	<keyword>midazolam</keyword>
	<keyword>patient comfort</keyword>
	<keyword>propofol</keyword>
</DOC>